Last reviewed · How we verify

NCT07295184

Effect of Rebound Pain on Postoperative Intensive Care Delirium in Patients Undergoing Hip Surgery With Peripheral Nerve Block

Not yet recruiting Last updated 29 December 2025
What this trial tests

trial testing Peripheral nerve block applied in Rebound Pain Impact After Hip Surgery With Nerve Block in 90 participants. Not yet recruiting.

Timeline
25 December 2025
Primary endpoint
25 December 2026
25 December 2026

Quick facts

Lead sponsorKonya City Hospital
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment90
Start date25 December 2025
Primary completion25 December 2026
Estimated completion25 December 2026

Drugs / interventions tested

Conditions studied

Sponsor

Konya City Hospital

Who can join

Adults 18 to 80, any sex, with Rebound Pain Impact After Hip Surgery With Nerve Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative delirium is a significant and commonly encountered complication in patients undergoing hip surgery, particularly among the elderly. Postoperative delirium is associated with serious consequences, including prolonged intensive care unit stay, increased complication rates, higher mortality risk, and rising healthcare costs. The incidence of Postoperative delirium after hip fracture surgery has been reported to range between 13% and 55.9%, indicating a substantial clinical burden. Effective postoperative pain control is critical not only for maintaining quality of life but also for preserving cognitive well-being. In this context, peripheral nerve blocks are frequently used for pain management following hip surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Konya City Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07295184.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing